Acrisure Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,515
Closed -$855K 124
2023
Q1
$855K Sell
5,515
-2,003
-27% -$323K 0.87% 15
2022
Q4
$1.33M Buy
+7,518
New +$1.3M 1.47% 1

Other funds holding JNJ

Acrisure Capital Management's JNJ Position: Q2 2023 in Review

Acrisure Capital Management sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 5,515 shares — an estimated $855K sold.

Acrisure Capital Management first reported a position in JNJ in Q4 2022 and held it in 2 quarters. The position peaked at $1.33M in Q4 2022. 3,751 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • Acrisure Capital Management reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
  • Acrisure Capital Management sold 5,515 Johnson & Johnson shares in Q2 2023, an estimated $855K.
  • Acrisure Capital Management first reported a position in Johnson & Johnson in Q4 2022 and held it in 2 quarters.
  • Acrisure Capital Management's Johnson & Johnson position peaked at $1.33M in Q4 2022.
  • 3,751 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Acrisure Capital Management's 13F filing for Q2 2023.